Browsing by Author Xu, Xiangjin
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
| May-2020 | Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial | Wang, Wei; Yao, Jun; Guo, Xiaohui; Guo, Yushan; Yan, Chaoli; Liu, Kuanzhi; Zhang, Ying; Wang, Xiaoyue; Li, Hongmei; Wen, Zhongyuan; Wang, Xinling; Li, Shuangqing; Xiao, Xinhua; Liu, Weijuan; Li, Ziling; Zhang, Lihui; Shao, Shiying; Ye, Handong; Qin, Guijun; Li, Yiming; Li, Feng; Zhang, Xiaomei; Li, Xuefeng; Peng, Yongde; Deng, Hongyan; Xu, Xiangjin; Zhou, Ligang; Huang, Yanli; Cao, Mengya; Xia, Xuefang; Shi, Mingbiao; Dou, Jing; Yuan, Jing |
| 2019 | Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial | Yang, Wenying; Ma, Jianhua; Hong, Tianpei; Liu, Ming; Miao, Heng; Peng, Yongde; Wang, Changjiang; Xu, Xiangjin; Yang, Tao; Nielsen, Anne M.; Pan, Lili; Liu, Weihong; Zhao, Weigang |
| 2018 | Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial | Mu, Yiming; Liu, Xiaomin; Li, Quanmin; Chen, Kangning; Liu, Yu; Lv, Xiaofeng; Xu, Xiangjin; Fan, Dongsheng; Shang, Ningxiu; Yang, Ruoyong; Pauer, Lynne; Pan, Changyu |
